NCT03296683Unknown不适用
Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast Cancer
适应症
干预措施
试验速览
- 阶段
- 不适用
- 入组人数
- 1,200
- 试验地点
- 1
- 主要终点
- Increase in incremental cancer detection rate
研究概览
简要总结
The study objective is to evaluate the added value of MIRA technology as an adjunct to mammography in the detection of malignant breast lesions in women with dense breast and/or at elevated risk of breast cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 24 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •**Calibration Phase:
- •A.Subjects who are asymptomatic and scheduled to undergo routine screening mammography.
- •B.Subjects scheduled for image guided needle biopsy as a result of findings obtained during standard of care (mammography, ultrasound and/or MRI)
- •**Testing Phase:
- •A. Subjects scheduled to undergo routine screening mammography and at least one of the following :
- •Subjects whose most recent (within 3 years) prior mammogram was interpreted as heterogeneously dense (ACR BI-RADS Breast Density 3) or extremely dense (ACR BI-RADS Breast Density 4).
- •Subjects whose current 10-year IBIS breast cancer risk is 5% or higher.
- •EXCLUSION CRITERIA, valid for both calibration and testing phases:
- •Male by birth.
- •Individual is less than 24 years old.
- •Contraindication to bilateral mammography or MRI.
- •Subjects who are unable to read, understand and execute the informed consent procedure.
- •Subjects who have had mammography, ultrasound or MRI examination performed on the day of the study prior to MIRA scan.
- •Subjects who have significant existing breast trauma.
- •Subjects who have undergone lumpectomy/mastectomy.
- •Subjects who have undergone breast reduction or breast augmentation.
- •Subjects who have undergone any other type of breast surgery.
- •Subjects who have large breast scar / Breast deformation.
- •Subjects who have undergone a breast needle biopsy within the 6 month period prior to their intended enrollment into the study.
- •Subjects who have a temperature > 100° F (37.8C) degrees on the day of the MIRA imaging.
- •Subjects who are pregnant or lactating.
- •Subjects who have had placement of an internal breast marker.
- •Subjects with known Raynaud's Disease.
- •Subjects that are claustrophobic or have physical limitations that do allow them to sit in the system chair for the required imaging session.
- •Subjects with implanted pacemaker/defibrillator, implanted venous access device (portacath) or other implanted devices.
- •Subjects with a BI-RADS category 6 (e.g. for which mammogram was performed for the purpose of planning cancer therapy).
- •Subjects affected with epilepsy.
- •Subjects who participated in the Calibration Phase will not be able to participate in the Testing Phase.
排除标准
- 未提供
研究组 & 干预措施
MIRA device imaging
Experimental
MIRA Device imaging for adjunctive detection of breast cancer
干预措施: MIRA device imaging (Device)
结局指标
主要结局
Increase in incremental cancer detection rate
时间窗: 24 months
Statistically significant increase of 30% or more in incremental cancer detection rate
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
终止
不适用
Evaluation of a 3D Functional Metabolic Imaging and Risk Assessment System for Classifying Women at High Risk of Breast CancerBreast CancerNCT02777164Real Imaging Ltd.740
Unknown
不适用
Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast CancerBreast CancerNCT03080155Real Imaging Ltd.680
终止
不适用
Visualization Tool for Investigation of Breast LesionsBreast LesionsNCT00934297Sunnybrook Health Sciences Centre10
进行中（未招募）
不适用
MRI Characterization of Mammographically Detected DCISBreast Cancer, Stage 0NCT03495011University of Washington122
已完成
不适用
Dual-energy Contrast-enhanced (2D and 3D Mammography Versus Contrast-enhanced MRI)- A Pilot StudyBreast CancerNCT01433640Hologic, Inc.30